Skip to content

Dydrogesterone

  • Prescription medicine
  • Varies by country
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Dydrogesterone does in the body

RNAWiki has not recorded what this substance changes in the body.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
Professional supervision is normally required. It is a prescription or clinician-administered medicine where it is approved.

What the registries record it as

  • The substance registry classes this as chemical.

    FDA substance registry · 90I02KLE8K · read 2026-08-29

  • Its recorded molecular formula is C21H28O2, weighing 312.4.

    PubChem record · 9051 · read 2026-08-29

Where each sentence above came from

No plain explanation of what this changes is stored.

No recorded use is stored in reader language.

No statement of the main limit is recorded.

The four opening statements run to 26 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Protein

A protein is a folded chain your body builds to do a specific job.

A picture of it, and where the picture fails

A protein is like a tool bent into one shape for one task.

Where that stops being true. A tool keeps its shape. A protein can change shape and stop working.

What people get wrong. Protein in food and a protein in the body are related but not the same thing.

A polymer of amino acids folded into a defined structure that determines its function.

Enzyme

An enzyme is a protein that speeds up one chemical change.

A picture of it, and where the picture fails

An enzyme is like a machine on a production line doing one cut.

Where that stops being true. A machine is switched on and off by a person. Enzymes are controlled by the cell.

What people get wrong. Enzymes are thought to be used up. They are not; they work again and again.

A catalytic protein that lowers the activation energy of a specific reaction.

Receptor

A receptor is a part of a cell that a signal fits into.

A picture of it, and where the picture fails

A receptor is like a lock waiting for one key.

Where that stops being true. A lock either opens or does not. A receptor can be half-triggered, or worn out.

What people get wrong. Fitting a receptor is read as causing a benefit. It causes a step, and nothing more.

A protein that binds a specific ligand and converts that binding into a cellular response.

Pathway

A pathway is a chain of steps inside a cell, each one setting off the next.

A picture of it, and where the picture fails

A pathway is like a row of dominoes.

Where that stops being true. Dominoes fall one way. Pathways loop back and can switch themselves off.

What people get wrong. Changing one step is read as changing the outcome. Other steps often absorb it.

An ordered series of molecular interactions producing a defined cellular change.

What happened in peopleRead from sources, not yet reviewed

What was measured, goal by goal

One row for each goal a registered study measured something for. One column for each kind of thing that could be measured.

Registered studies list 30 outcome measures that RNAWiki could read. A registered study says what someone planned to measure. It does not say what they found. 0 of the matched studies tested this substance, and 0 posted a result.

There is no single score. A strong test result and a weak life result are different facts.

Goals down the side, kinds of measurement across the top. Each cell says what kind of thing was registered, not what was found.
GoalLife outcomeWhat a body can doHow a person feelsA test resultA step in the bodyHarmsHow longWho was studied
Fertility and sexual healthNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Which registered measures put each goal on this table
Fertility and sexual health
fertilization rate

Sorted by fixed word lists, version v1. A name the rules do not recognise stays unsorted rather than moving to the nearest column.

What each mark on this table means
Nothing in the sources checked
No registered study lists a life outcome for this goal.
Not recorded
Harms were not a registered measure for this goal.
Waiting for a reviewer
Who was studied is listed further down the page.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Rate of preterm delivery

The study did not show it

Who was studied
NCT03428685
How many people
1714
Study design
Phase 2/Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Live birth rate

The study did not show it

Who was studied
NCT03998761
How many people
1364
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Percentage of Participants Being Pregnant as Measured by the Presence of Fetal Heart Beats at 12 Weeks´Gestation Using Transvaginal Ultrasound

The study did not show it

Who was studied
NCT01850030
How many people
1070
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Percentage of Participants With Presence of Fetal Heart Beats at 12 Week's Gestation Determined by Transvaginal Ultrasound

The study did not show it

Who was studied
NCT02491437
How many people
1034
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Ongoing pregnancy rate

The study did not show it

Who was studied
NCT01178931
How many people
853
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

live birth rate

The study did not show it

Who was studied
NCT04414761
How many people
784
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event No evidence recorded. Death, a heart attack, a stroke, a hospital stay.No registered study measures this.
  2. What a body can do day to day No evidence recorded. Walking, dressing, breathing, recovering.No registered study measures this.
  3. Measured performance No evidence recorded. How much was lifted, how far was run, how fast.No registered study measures this.
  4. Symptoms and quality of life No evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.No registered study measures this.
  5. A number that stands in for health No evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.No registered study measures this.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
  7. Animals Evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.Stored records in Rat. A result in animals says what to test next. It does not say what happens in people.
  8. Cells in a dish No evidence recorded. Cells or chemistry on a bench, far from a whole body.No cell or bench record is stored.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

No description of who was studied is recorded.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (10)
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Varies by country

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No form or route is recorded.

No source is stored against this line.

Who oversees it

Professional supervision is normally required. It is a prescription or clinician-administered medicine where it is approved.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

A register records the withdrawal of an approval.

No source is stored against this line.

What is in the pack

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing is recorded about product quality.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Reports sent to a regulator

  • These are reports people sent to a regulator. They do not show the medicine caused the reaction.
  • Nobody counted how many people took the medicine and reported nothing.
  • The same event can be reported more than once, and many reports are incomplete.
  • News coverage, lawsuits and new warnings change how often people report.
  • A count is not a rate and not a risk.

Dydrogesterone appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 68 reaction mentions were counted. One report can name several reactions.

The recorded terms (10)
  • ovarian hyperstimulation syndrome — 10 reaction mentions
  • placenta accreta — 8 reaction mentions
  • coma — 7 reaction mentions
  • premature baby — 7 reaction mentions
  • optic neuritis — 6 reaction mentions
  • ovarian atrophy — 6 reaction mentions
  • ovarian failure — 6 reaction mentions
  • pelvic infection — 6 reaction mentions
  • poisoning deliberate — 6 reaction mentions
  • pre-eclampsia — 6 reaction mentions
  • open-targets-adr · recorded 2026-06-24 · a recorded source, not a stored snapshot

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

The exact form studied is not recorded.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 7 products list this as an active ingredient in the United States drug directory. 7 of them contain it and nothing else.

    FDA National Drug Code directory · 64918-1905 · read 2026-08-29

  • They are sold as powder.

    FDA National Drug Code directory · 64918-1905 · read 2026-08-29

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

Self-experiment planning is not offered for a prescription or clinician-supervised medicine, withdrawn medicine. The questions below are for a clinician or pharmacist.

Questions worth asking

  • Which of the trials of Dydrogesterone studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

How fast does the body clear it?

The sources RNAWiki checked hold nothing for this field.

Why it matters. Without this, nothing on this page can say how long anything lasts.

What would answer it

A stored source that records it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Dydrogesterone are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Where else this substance is registered

FDA substance identifier (UNII)
90I02KLE8K
CAS registry number
152-62-5
PubChem compound
9051
ChEMBL
CHEMBL1200853
ChEBI
31527
WHO international nonproprietary name list entry
970
RxNorm concept
3706
EMA substance identifier
100000080500
European Chemicals Agency number
205-806-8
DrugBank
DB00378

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Not passed

    Every public sentence names a source

    The opening statement carries no source: the record holds neither an explanation nor a recorded use.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    A register records the withdrawal of an approval.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 1 approved application covers products containing this substance.

    Drugs@FDA application register · NDA017388 · read 2026-08-29

  • Marketing status on the register: discontinued.

    Drugs@FDA application register · NDA017388 · read 2026-08-29

  • The earliest marketing start date recorded for a listed product is 20190111.

    FDA National Drug Code directory · 64918-1905 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

7 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • The path through the body — found nothing in the sources checked.
  • Felt, measured, or meaningful — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (11)

What did Dydrogesterone's largest trial (1714 people) and its longest (5.8 years) measure?


1714 people in Dydrogesterone's largest registered study, 5.8 years in its longest registered window, measuring Cytokine ratio IFN/IL-10. ClinicalTrials.gov · 2026-09-01

17 phase3, 16 na, 12 phase4, 7 na or unstated, 5 phase2, 1 early phase1; NCT00193674; 2009-07; no ageing endpoint recorded. Last human test completed 2026, NCT07608133.

Interpretation These counts include studies where Dydrogesterone was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • phase3
    17
  • na
    16
  • phase4
    12
  • na or unstated
    7
  • phase2
    5
  • early phase1
    1
1 more recorded row
  • Last recorded human test NCT07608133
    2026-05-15

recorded 2026-09-01 · last checked 2026-09-04

From rat to human: where has Dydrogesterone shown mechanism-only?


rat: mechanism-only and human: mechanism-only (54): the rungs where Dydrogesterone has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Cytokine ratio IFN/IL-10 — the recorded outcome words.

Yeast C. elegans Drosophila Mouse Rat mechanism-onlyDog Non-human primate Human mechanism-only
Show the evidence
  • rat
    mechanism-only
  • human NCT00193674
    mechanism-only; Cytokine ratio IFN/IL-10; 54

recorded 2026-09-01 · last checked 2026-09-04

2 of Dydrogesterone's trials stopped: accrual/recruitment, other?


accrual/recruitment (1) and other (1): Dydrogesterone's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"The study was terminated due to difficulty in recruiting patients."; 2 of 54 registered studies

Show the evidence

Trial

  • NCT03680053
    terminated; "The study was terminated due to difficulty in recruiting patients."
  • NCT03858049
    terminated; "The trend in LPS treatment tends to increase the dosage of progesterone in FET-HRT, this study was designed 5 years ago."

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Dydrogesterone used Dydrogesterone 30 mg — over how long?


Human studies of Dydrogesterone used "Dydrogesterone 30 mg". ClinicalTrials.gov · 2026-09-01

8 recorded entries; human; also "Dydrogesterone 10 mg", "duphaston 10 mg", "Dydrogesterone 10 MG"

Show the evidence

human

  • NCT01850030
    Dydrogesterone 30 mg
  • NCT03456570
    Dydrogesterone 10 mg
  • NCT03456570
    duphaston 10 mg
  • NCT03675139
    Dydrogesterone 10 MG
  • NCT03948022
    Dydrogesterone 10Mg Tablet (duphaston)
  • NCT04124913
    Dydrogesterone 10 MG Oral Tablet
2 more recorded rows
  • human NCT04408144
    Dydrogesterone 10mg Oral Tablet
  • human NCT06812559
    Duphaston 10mg Tablets

recorded 2026-09-01 · last checked 2026-09-04

Could one person measure Dydrogesterone's effect on ongoing pregnancy rate?


Ongoing pregnancy rate: measured in Dydrogesterone's trials.

Interpretation ongoing pregnancy rate is the recorded endpoint.

Show the evidence

biomarkers

  • ongoing pregnancy rate; 2026-09-01
  • improving of sleeping quality; 2026-09-01
  • live birth rate; 2026-09-01
  • preterm delivery before 34 and 37 weeks; 2026-09-01
  • live birth; 2026-09-01
  • prolongation of pregnancy; 2026-09-01
14 more recorded rows
  • biomarkers
    second diagnostic hysteroscopy; 2026-09-01
  • biomarkers
    rate of preterm delivery; 2026-09-01
  • biomarkers
    gestational age in weeks at delivery; 2026-09-01
  • biomarkers
    pathological complete response rates; 2026-09-01
  • biomarkers
    molecular endometrial level using illumina rna seq; 2026-09-01
  • biomarkers
    molecular endometrial level using immunohistochemistry; 2026-09-01
  • biomarkers
    molecular endometrial level using flow cytometry; 2026-09-01
  • biomarkers
    latency period; 2026-09-01
  • biomarkers
    euploidy rate; 2026-09-01
  • biomarkers
    m2 oocytes retrieved; 2026-09-01
  • biomarkers
    fertilization rate; 2026-09-01
  • biomarkers
    resultant embryos number; 2026-09-01
  • biomarkers
    implantation rate; 2026-09-01
  • biomarkers
    clinical pregnancy rate; 2026-09-01
  • human trials at or under30
    1
  • Not recorded for this substance
    a recorded half-life
  • smallest human trial
    30; NCT03677336; PHASE4; the smallest recorded human enrolment at or below 30; the registry states no direction of its result; COMPLETED

Which of clinical pregnancy, clinical pregnancy rate and efficacy did Dydrogesterone's trials measure?


clinical pregnancy, clinical pregnancy rate and efficacy lead 30 outcome terms across Dydrogesterone's trials. ClinicalTrials.gov · 2026-09-01

preterm delivery before 34 and 37 weeks, live birth, prolongation of pregnancy, second diagnostic hysteroscopy, rate of preterm delivery and gestational age in weeks at delivery follow.

Show the evidence
  • ongoing pregnancy rate
    1
  • improving of sleeping quality
    1
  • live birth rate
    1
  • preterm delivery before 34 and 37 weeks
    1
  • live birth
    1
  • prolongation of pregnancy
    1
14 more recorded rows
  • second diagnostic hysteroscopy
    1
  • rate of preterm delivery
    1
  • gestational age in weeks at delivery
    1
  • pathological complete response rates
    1
  • molecular endometrial level using illumina rna seq
    1
  • molecular endometrial level using immunohistochemistry
    1
  • molecular endometrial level using flow cytometry
    1
  • latency period
    1
  • euploidy rate
    1
  • m2 oocytes retrieved
    1
  • fertilization rate
    1
  • resultant embryos number
    1
  • implantation rate
    1
  • clinical pregnancy rate
    1

recorded 2026-09-01 · last checked 2026-09-04

Which of Dydrogesterone's 4 ongoing trials reports first?


4 registered trials of Dydrogesterone are open; earliest completion 2026-06-30. ClinicalTrials.gov · 2026-09-01

live birth rate; Ongoing pregnancy; latest 2027-10

Show the evidence

Trial

  • NCT03859921
    "Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET"; n 716; "live birth rate"; 2026-11-30
  • NCT06378268
    "PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)"; n 626; "Ongoing pregnancy"; 2026-09-30
  • NCT06952296
    "Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain"; n 250; "Changes in visual analogue scale (VAS) score of dysmenorrhea, Chronic Pelvic Pain (CPP), dyspareunia, and other Endometriosis related Pain (ERP) after dydrogesterone treatment from baseline to Cycle 6."; 2026-06-30
  • NCT07496294
    "Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy"; n 200; "Endometrial Thickness"; 2027-10

recorded 2026-09-01 · last checked 2026-09-04

Which 18 trials of Dydrogesterone posted no result?


Posted no result
18 of 18 completed trials
Registrations
NCT00193674, NCT01178931, NCT02262481, NCT02086032, NCT02989519 and NCT03309735, and 12 more
Completion dates
oldest 2009-07; newest 2024-06-13
Show the evidence

Trial

  • NCT00193674
    2009-07
  • NCT01178931
    2013-12
  • NCT02262481
    2015-06
  • NCT02086032
    2015-07
  • NCT02989519
    2017-03-01
  • NCT03309735
    2017-12-22
12 further recorded trials
  • NCT02128685
    2018-05-31
  • NCT03790215
    2019-12-31
  • NCT04287205
    2020-03-03
  • NCT03690765
    2020-05-29
  • NCT03935152
    2020-05-31
  • NCT03677336
    2020-08-24
  • NCT03948022
    2021-12-20
  • NCT05577806
    2021-12-31
  • NCT03675139
    2022-05-15
  • NCT04788108
    2022-08-31
  • NCT04414761
    2022-10-10
  • NCT04758871
    2024-06-13

At the median, Dydrogesterone's trials enrolled 200 people — anything larger?


Median enrolment
200
Largest enrolment
1714
Registered trials counted
54

What do 68 spontaneous reports say about Dydrogesterone — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Dydrogesterone appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 68 reaction mentions were counted: ovarian hyperstimulation syndrome 10; placenta accreta 8; coma 7; premature baby 7. open-targets-adr · CHEMBL1200853 · 2026-06-24

Show the evidence
  • ovarian hyperstimulation syndrome
    10
  • placenta accreta
    8
  • coma
    7
  • premature baby
    7
  • optic neuritis
    6
  • ovarian atrophy
    6
4 more recorded rows
  • ovarian failure
    6
  • pelvic infection
    6
  • poisoning deliberate
    6
  • pre-eclampsia
    6

recorded 2026-06-24 · last checked 2026-09-04

Was Dydrogesterone studied with fasting?


fasting is named in Dydrogesterone's label sentences: "In a randomized, double blind study, we examined the effects of 6-month treatment with daily 17 beta-estradiol (E2; 2 mg, orally) continuously combined with one of four dosages [2.5 mg (n = 41), 5 mg (n = 38), 10 mg (n = 38), and 15 mg (n = 20)] of dydrogesterone on fasting serum Lp(a)…" openfda-label+europepmc · 1997-11-01

1 recorded statement; fasting

Show the evidence
  • fasting
    In a randomized, double blind study, we examined the effects of 6-month treatment with daily 17 beta-estradiol (E2; 2 mg, orally) continuously combined with one of four dosages [2.5 mg (n = 41), 5 mg (n = 38), 10 mg (n = 38), and 15 mg (n = 20)] of dydrogesterone on fasting serum Lp(a) concentrations in 137 healthy postmenopausal women.

recorded 1997-11-01 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL1200853
PubChem CID
9051
CAS number
152-62-5
RxCUI
3706
InChIKey
JGMOKGBVKVMRFX-HQZYFCCVSA-N
Also called
Didrogesterona, Isopregnenone, duphastone, progestin, DYDROGESTERONE [EP MONOGRAPH], DYDROGESTERONE [HSDB], DYDROGESTERONE [JAN], DYDROGESTERONE [MART.], DYDROGESTERONE [MI], DYDROGESTERONE [ORANGE BOOK], DYDROGESTERONE [USAN], DYDROGESTERONE [USP MONOGRAPH]
Trade name
Duphaston, Duphaston-hrt, Gynorest
Development code
NSC-92336
Sources (8)

Sources

2 more sources

ChEMBL ATC CC BY-SA · ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · Open Targets 26.06 — CC0 · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 4 required field(s) not terminal: Best-supported result, Most important common problem, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 8 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.